Wide Neck Aneurysm

2

Review clinical trials related to Wide Neck Aneurysm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Early Complications After Flow Diverter Versus Stent-Assisted Coiling for Unruptured Wide-Neck Intracranial Bifurcation Aneurysms

This prospective real-world cohort study aims to compare early postoperative complications between flow diverter treatment and stent-assisted coiling in patients with unruptured wide-neck intracranial bifurcation aneurysms. A total of 274 patients from three centers in China will be enrolled and assigned to the flow diverter group or the stent-assisted coiling group according to the treatment received in routine clinical practice. The primary outcome is a composite of any stroke or all-cause death within 30 days after the procedure. The study will also collect demographic, clinical, laboratory, imaging, aneurysm morphological, procedural, and follow-up data to evaluate the safety of these two endovascular treatment strategies in a real-world setting.

Participants needed: 274
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Nanfang Hospital, Southern Medical UniversityUpdated: Aug 10, 2026Locations: 3Duration: 30 Days
Eligibility criteria

Voluntarily provides written informed consent. [+3]

Patients with two or more multiple aneurysms, all of which require treatment wit... [+14]

Status: Recruiting

Targeting Real World Usage In Stroke Treatment

TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices. The overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.

Participants needed: 5,000
Trial details
Biological sex: AllType: ObservationalSponsor: Phenox GmbHUpdated: Mar 16, 2026Locations: 13Duration: 5 Years
Eligibility criteria

Subject treated or intended to be treated with at least one target registry devi... [+1]

Participation in an interventional study modifying standard care management for...